Medications such as Wegovy and Zepbound will no longer be covered for weight loss, although GLP-1 drugs for diabetes will still be approved.

Aetna members in California can now access the MD-03 Protocol™ at lower monthly costs, making personalized skin health ...

Press Ganey, a leading global provider of experience technology, data analytics, and AI-powered insights, announced Aetna, a division of CVS ...

Five of its eight planned clinics will be in in former Rite Aid stores.

The collaboration will place an emphasis on targeted populations living with hypertension in Illinois, Kentucky, Michigan and ...

Despite there being a lot more growth in the mental health industry in general, not everyone is fully aware of the opportunities out there and the help available. In this guide, w ...

CVS Health Corporation (NYSE:CVS) Q4 2025 Earnings Call Transcript February 10, 2026 CVS Health Corporation beats earnings expectations. Reported EPS is $1.09, expectations were $1. Operator: Hello, ...

CVS Health’s rehabilitation efforts to return to full strength appear to be on track after a strong fourth quarter. The ...

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health this morning reported earnings in line with expectations. In 2025, the giant healthcare company saw record earnings of $402.1 billion, up 7.8% compared with the year before. The lull-year ...

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.

For 2026, the healthcare conglomerate maintained ‌a full-year adjusted profit forecast between $7.00 and $7.20 per share, ...